Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


24th week of 2012 patent applcation highlights part 53
Patent application numberTitlePublished
20120149741TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY - There are provided compounds of Formula (I) wherein three of A2012-06-14
20120149742HETEROCYCLIC DERIVATIVES AS MODULATORS OF ION CHANNELS - The present invention relates to heterocyclic derivatives useful as inhibitors of ion channels. The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various disorders.2012-06-14
20120149743Selenophene and Selenazole Carboxylic Acid Derivatives - Derivatives of selenophene and selenazole heterocycles are disclosed. The compounds are useful as inhibitors of D-amino acid oxidase (DAO) and in the treatment of neurodegenerative and psychiatric diseases and disorders.2012-06-14
20120149744ANTI-MITOTIC ANTI-PROLIFERATIVE COMPOUNDS - Substituted triazole compounds and pharmaceutical compositions thereof are presented. Also presented are methods for treating a pathology linked to a hyperproliferative disorder by administering the substituted triazole compounds to a patient in need thereof.2012-06-14
20120149745ANTIMYCOTIC PHARMACEUTICAL COMPOSITION - A pharmaceutical composition which comprises 1) a compound represented by the following general formula (1) and/or a salt thereof; and 2) a ketone such as methyl ethyl ketone. Preferably, the compound represented by the following general formula (1) is luliconazole, where R2012-06-14
20120149746ESTER PRO-DRUGS OF [3-(1-(1H-IMIDAZOL-4-YL)ETHYL)-2-METHYLPHENYL] METHANOL FOR TREATING RETINAL DISEASES - The present invention relates to method of treating retinal diseases in a subject in need of such treatment, which comprises administering a therapeutically effective amount of a composition comprising a ester pro-drugs of [3-(1-(1H-imidazol-4-yl)ethyl)-2-methylphenyl]methanol, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals.2012-06-14
20120149747PHARMACEUTICAL COMPOSITIONS COMPRISING (3-(1-(1H-IMIDAZOL-4-YL)ETHYL)-2-METHYLPHENYL)METHANOL - The present invention relates to method of lowering intraocular pressure in a subject in need of such treatment, which comprises administering a therapeutically effective amount of a composition comprising [3-(1-(1H-imidazol-4-yl)ethyl)-2-methylphenyl]methanol, or enantiomers thereof, or tautomers thereof, pharmaceutical compositions containing them and their use as pharmaceuticals.2012-06-14
20120149748Pharmaceutical Cream Compositions and Methods of Use - The present invention provides pharmaceutical cream compositions comprising oxymetazoline and methods for treating rosacea and other skin disorders as described herein using the above cream compositions.2012-06-14
20120149749METHOD OF TREATING THROMBOCYTOPENIA - Invented is a method of treating thrombocytopenia in a human in need thereof which comprises the administration of a therapeutically effective amount of a 3′-{N′-[1-(3,4-Dimethylphenyl)-3-methyl-5-oxo-1,5-dihydropyrazol-4-ylidene]hydrazino}-2′-hydroxybiphenyl-3-carboxylic acid to such human.2012-06-14
20120149750ARYLOAZOL-2-YL CYANOETHYLAMINO COMPOUNDS, METHOD OF MAKING AND METHOD OF USING THEREOF - The present invention relates to novel aryloazol-2-yl-cyanoethylamino derivatives of formula (I):2012-06-14
20120149751Antiviral Drugs for Treatment of Arenavirus Infection - Compounds, methods and pharmaceutical compositions for treating viral infections, by administering certain novel compounds in therapeutically effective amounts are disclosed. Methods for preparing the compounds and methods of using the compounds and pharmaceutical compositions thereof are also disclosed. In particular, the treatment and prophylaxis of viral infections such as caused by hemorrhagic fever viruses is disclosed, i.e., including but not limited to, Arenaviridae (Junin, Machupo, Guanarito, Sabia, Lassa, Tacaribe, and Pichinde), Filoviridae (Ebola and Marburg viruses), Flaviviridae (yellow fever, Omsk hemorrhagic fever and Kyasanur Forest disease viruses), and Bunyaviridae (Rift Valley fever).2012-06-14
20120149752KIT FOR BALANCING NEUROTRANSMITTER LEVELS - The teachings provided herein generally relate to formulations, systems, and methods that have the ability to remit deficiencies and imbalances in a subject's serotonin and dopamine levels. The teachings relate to the preparation and uses of a formulation comprising a serotonergic agent or dopaminergic agent in a form capable of oral transmucosal delivery to a subject. The formulation includes a flavoring agent and a carrier base. The flavoring agent functions as a taste indicator of the endpoint of a taste titration of the serotonergic or dopaminergic agent for a subject receiving an oral administration of the formulation in the form of a taste titration, and the endpoint is indicated to the subject by a change in the intensity of the flavor of the flavoring agent.2012-06-14
20120149753USE OF NOVEL COMPOUNDS FROM FRUITING BODY OF ANTRODIA CAMPHORATA FOR TREATING AN INFLAMMATORY DISORDER - Disclosed herein are isolated compounds or pharmaceutically acceptable salts thereof, which exhibit immunostimulatory or anti-inflammatory effects. The compounds are isolated from the fruiting body of 2012-06-14
20120149754METHODS FOR MODULATING THE EXPRESSION AND AGGREGATION OF CAG-EXPANDED GENE PRODUCT IN CELLS AND METHODS FOR IDENTIFYING AGENTS USEFUL FOR DOING THE SAME - This invention provides a method for modulating the expression of a first gene in a cell wherein the first gene is one containing more than 36 CAG trinucleotide repeats and encoding a protein that form polyglutamine-mediated protein aggregation. Suppression of the first gene is achieved by reducing the expression of SPT4 gene or SUPT4H gene. It can also be achieved by inhibiting the formation of a Spt4/Spt5 complex or a Supt4h/Supt5h complex. Also provided is a method for identifying an agent useful for modulating the expression and aggregation of CAG-expanded gene product, or treating a polyglutamine disease such as Huntington's disease.2012-06-14
20120149755ANTISENSE OLIGONUCLEOTIDE MODULATION OF RAF GENE EXPRESSION - Oligonucleotides are provided which are targeted to nucleic acids encoding human raf and capable of inhibiting raf expression. The oligonucleotides may have chemical modifications at one or more positions and may be chimeric oligonucleotides. Methods of inhibiting the expression of human raf using oligonucleotides of the invention are also provided. The present invention further comprises methods of inhibiting hyperproliferation of cells and methods of treating or preventing conditions, including hyperproliferative conditions, associated with raf expression.2012-06-14
20120149756TRICYCLO-DNA ANTISENSE OLIGONUCLEOTIDES, COMPOSITIONS, AND METHODS FOR THE TREATMENT OF DISEASE - Provided are tricyclo-DNA (tc-DNA) AON and methods employing tc-DNA AON for modifying splicing events that occur during pre-mRNA processing. Tricyclo-DNA (tc-DNA) AON are described that may be used to facilitate exon skipping or to mask intronic silencer sequences and/or terminal stem-loop sequences during pre-mRNA processing and to target RNase-mediated destruction of processed mRNA. Tc-DNA AON described herein may be used in methods for the treatment of Duchenne Muscular Dystrophy by skipping a mutated exon 23 or exon 51 within a dystrophin gene to restore functionality of a dystrophin protein; in methods for the treatment of Spinal Muscular Atrophy by masking an intronic silencing sequence and/or a terminal stem-loop sequence within an SMN2 gene to yield modified functional SMN2 protein, including an amino acid sequence encoded by exon 7, which is capable of at least partially complementing a non-functional SMN1 protein; and in methods for the treatment of Steinert's Myotonic Dystrophy by targeting the destruction of a mutated DM1 mRNA comprising 3′-terminal CUG repeats.2012-06-14
20120149757COMPOSITIONS AND METHODS FOR MODULATION OF SMN2 SPLICING - Disclosed herein are compounds, compositions and methods for modulating splicing of SMN2 mRNA in a cell, tissue or animal. Also provided are uses of disclosed compounds and compositions in the manufacture of a medicament for treatment of diseases and disorders, including spinal muscular atrophy.2012-06-14
20120149758PHARMACEUTICAL COMPOSITION FOR PREVENTING, STABILISING AND/OR INHIBITING BLOOD AND LYMPH VASCULARIZATION - A pharmaceutical composition including as active agent, an antisens oligonucleotide having the sequence SEQ ID NO: 1, wherein the antisens oligonucleotide is in a concentration from about 0.40 mg/ml to about 2 mg/ml and the use thereof for preventing, stabilizing and/or inhibiting blood and lymph vascularization.2012-06-14
20120149759TREATMENT OF INSULIN GENE (INS) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO AN INSULIN GENE (INS) - The present invention relates to antisense oligonucleotides that modulate the expression of and/or function of an Insulin gene (INS), in particular, by targeting natural antisense polynucleotides of an Insulin gene (INS). The invention also relates to the identification of these antisense oligonucleotides and their use in treating diseases and disorders associated with the expression of Insulin Gene (INS).2012-06-14
20120149760DISABLING AUTOPHAGY AS A TREATMENT FOR LYSOSOMAL STORAGE DISEASES - Provided herein are methods of treating lysosomal storage disease, for instance Pompe disease, through inhibition of autophagy. Optionally, treatment is administered as an adjunct to enzyme replacement therapy (ERT).2012-06-14
20120149761NUCLEIC ACID MOLECULES AND USES THEREOF - Provided in this application are formulations of double stranded RNA molecules and Krebs Cycle analogs that improving ribonuclease stability, reducing off-target effects of a double stranded siRNA molecule, or of reducing interferon responsiveness of a double stranded siRNA molecule using such dsRNA. Also disclosed are methods of treating a primary tumor or a metastasis by contacting circulating tumor cells, a primary tumor, or a metastasis with a described formulation.2012-06-14
20120149762Gene and Protein Relating to Hepatocellular Carcinoma and Methods of Use Thereof - The present invention provides a novel human gene ZNFN3A1 whose expression is markedly elevated in a great majority of HCCs compared to corresponding non-cancerous liver tissues. The gene encodes a protein having a zinc finger domain as well as a SET domain and has been found to form a regulatory complex with RNA helicase and RNA polymerase.2012-06-14
20120149763PHARMACEUTICAL COMPOSITION FOR TREATING ADVERSE REACTIONS DUE TO ADMINISTRATION OF SPIEGELMERS - The invention relates to the use of an L-ribozyme, which is capable of splitting an L-RNA in the region of a target sequence of the L-RNA, in order to produce a pharmaceutical composition for treating undesired physiological adverse reactions due to the administration of a therapeutic molecule containing the L-RNA. Alternatively, an endogenous target RNA may also be split by the L-ribozyme.2012-06-14
20120149764APTAMERS THAT BIND THROMBIN WITH HIGH AFFINITY - The invention provides aptamers capable of binding to thrombin useful as therapeutics for and diagnostics of coagulation related disorders and/or other diseases or disorders in which thrombin has been implicated. The invention further provides materials and methods for the administration of aptamers capable of binding to thrombin.2012-06-14
20120149765SGK1 AS DIAGNOSTIC AND THERAPEUTIC TARGET - The invention relates to the utilization of a substance for diagnostic determination of sgk1 (serum and glucocorticoid dependent kinase 1) and to the utilization of an active agent in order to influence sgk1 for therapeutic treatment of diseases associated with disordered activity of the tissue factor and to a diagnostic kit related to such substances or such active agents.2012-06-14
20120149766DIETARY AND PHARMACEUTICAL COMPOSITIONS COMPRISING A SAGE EXTRACT CONTAINING A MIXTURE OF TRICYCLIC DITERPENES AND THEIR DERIVATIVES AND THEIR USES - The present invention refers to a sage extract containing a mixture of tricyclic diterpene (derivative)s of the formulae I to III, preferably to a sage extract containing a mixture of tricyclic diterpene (derivative)s of the formulae I to IV, more preferably to a sage extract containing a mixture of tricyclic diterpene (derivative)s of the formulae I to V, for use as medicaments for the treatment of a disorder connected to reduced neurotransmission, as well as to dietary and pharmaceutical compositions and their uses.2012-06-14
20120149767Connection Device for a Submersible Connector - The invention relates to a device (2012-06-14
20120149768PKC-ACTIVATING COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES - The present invention relates to methods of activate an isoform of protein kinase C (PKC) for the treatment of neurological diseases including Alzheimer's disease and stroke using cyclopropanated or epoxidized derivatives of mono- and polyunsaturated fatty acids. The present invention also relates to methods of reducing neurodegeneration using cyclopropanated or epoxidized derivatives of mono- and polyunsaturated fatty acids.2012-06-14
20120149769Thiocarbonates as Anti-Inflammatory and Antioxidant Compounds Useful For Treating Metabolic Disorders - The invention is directed to thiocarbonate compounds of Formula (I)-(III) and methods of treating atherosclerosis, neuropathy, nephropathy, retinopathy, inflammatory disorders, COPD, cardiovascular diseases, metabolic disorders, type I diabetes mellitus, type II diabetes mellitus, LADA, Wolfram Syndrome 1, Wolcott-Rallison syndrome, metabolic syndrome, dyslipidemia, hyperglycemia, or insulin resistance. The compounds of the invention are also useful for protecting pancreatic beta-cells and for reducing free fatty acids, triglycerides, advanced glycated end products, ROS, lipid peroxidation, tissue and plasma TNFalpha and IL6 levels, or for delaying or preventing cardiovascular complications associated with atherosclerosis.2012-06-14
20120149770Antimicrobial Preservation of Propofol Emulsions - The invention provides intravenous formulations of propofol in an oil-in-water emulsion, having a combination of preservatives.2012-06-14
20120149771METHOD FOR TREATING AIRWAY HYPER-RESPONSIVENESS WITH LIPOXIN ANALOGS - The use of lipoxin analogs for the treatment or prevention of asthma and asthma related diseases is described. In particular, acetylenic lipoxin analogs are effective for the treatment and prevention of eosinophil recruitment involved with the inflammation processes associated with asthma, asthma like conditions, and lung injuries associated from airway inflammation or infection as brought about by leukocyte-mediated injury from within.2012-06-14
20120149772PROCESS FOR THE PREPARATION OF FESOTERODINE OR A SALT THEREOF - A process for the preparation of (R)-2-(3-diisopropylamino-1-phenylpropyl)-4-(hydroxymethyl)-phenol isobutyrate (Fesoterodine) or a pharmaceutically acceptable salt thereof having low content in impurities.2012-06-14
20120149773COMPOSITION FOR SKIN IMPROVEMENT COMPRISING HEXAMIDINES AND RETINOIDS - Disclosed is herein a composition comprising hexamidines, derivatives thereof, or pharmaceutically acceptable salts thereof; and retinoids, derivatives thereof, or pharmaceutically acceptable salts thereof, as an active ingredient. The composition of the present invention has effects for preventing, improving or treating acne; controlling sebum; pore-controlling; and preventing, improving or treating skin pigmentation. Also, the composition of the present invention could alleviate skin-irritations caused with retinoids by including ceramides.2012-06-14
20120149774COMPOSITIONS AND METHODS FOR NUTRIENT DELIVERY - The present disclosure provides compositions and methods for delivering nutrients to subjects requiring small-volume nutritional support, such as preterm infants. The compositions may comprise an emulsion of docosahexaenoic acid (DHA) and arachidonic acid (ARA). The nutritional compositions are useful, for example, in correcting nutritional deficiencies by increasing a subject's intake of nutrients, such as ω-3 or ω-6 long-chain polyunsaturated acids. The nutritional compositions are suitable for enteral delivery as a nutritional supplement or for oral delivery as a human milk or infant formula fortifier.2012-06-14
20120149775METHODS FOR PREVENTING AND IMPROVING SKIN ELASTIC PROPERTY LOSS - The present invention is directed to method for preventing and improving an aggravation of a skin condition accompanied with a skin elastic property loss by suppressing an increase in, or inhibiting the physiological activity of, palmitic acid. The present invention provides a cosmetic method for preventing and improving wrinkling and sagging accompanied with a skin elastic property loss and a method for preventing and treating a wound healing disorder and a bedsore.2012-06-14
20120149776PREPARATION FOR SUN PROTECTION - The invention relates to the use of norbixin and an urucum extract enriched in bixin and/or norbixin as a food. The invention also provides a food preparation comprising norbixin, bixin or an extract comprising at least bixin or norbixin, the preparation being intended to be administered orally, for the protection of mammalian skin against UV-radiation.2012-06-14
20120149777COMPOSITIONS AND METHODS FOR IMPROVING CELLULAR SURVIVAL AND REDUCING APOPTOSIS AFTER ISCHEMIC EPISODE IN THE BRAIN - Compositions and methods for enhancing vascular integrity in animals are disclosed. The compositions and methods, which utilize long chain polyunsaturated fatty acids and nitric oxide releasing compounds are also effective for reducing ischemia-induced brain injury in an animal.2012-06-14
20120149778COMPOUNDS - The invention provides compounds according to formula (I): (wherein X, Y, Z1 R1, R2, R3, Ar and Ar′ are as defined herein), and physiologically acceptable salts, solvates, esters or amides thereof, pharmaceutical compositions comprising these compounds and the compounds for use in medicine, for example for the treatment or prophylaxis of diseases involving cell proliferation, such as cancer, and for the treatment or prophylaxis of other diseases.2012-06-14
20120149779HIGH CONCENTRATION LOCAL ANESTHETIC FORMULATIONS - A transdermal topical anesthetic formulation, which can be used to ameliorate or inhibit pain, has been developed. In the preferred embodiment, the topical anesthetic is a local anesthetic such as lidocaine, most preferably lidocaine free-base in a gel, and the dosage of the local anesthetic is effective in the painful area or immediately adjacent areas, to ameliorate or eliminate the pain. High concentration of local anesthetic in solution in the carrier is used to drive rapid release and uptake of the drug. Relief is typically obtained for a period of several hours.2012-06-14
20120149780Method of Use of Vitamin K as Energy Enhancer in Diverse Disease States - The invention relates to Vitamin K, its derivatives and combinations to increase the energy levels in diverse disease states and life style disorders, which are characterized by low energy level due to inadequate VO22012-06-14
20120149781STEM CELL DIFFERENTIATION USING NOVEL LIGHT-RESPONSIVE HYDROGELS - This application discloses a light-responsive hydrogel-based platform that can modulate multiple microenvironmental signals to direct the differentiation of human induced pluripotent stem cell-derived neural progenitor cells (hiPSC-NPCs) into neuronal cells. The invention provides novel methods for directing differentiation of neural stem cells into neurons useful for treatment of degenerative diseases or disorders, including but not limited to Alzheimer's, Parkinson's, or spinal cord injury (SCI).2012-06-14
20120149782CAROTENOID COMPOSITIONS CONTAINING MODIFIED GUM ACACIA - Compositions containing modified gum acacia, less than 40% oil and carotenoids, where the gum acacia has been subjected to a heat-treatment at a temperature between 100° C. and 115° C. for 1 to 38 hours. These compositions allow preparation of emulsions having a very high color intensity and color stability and useful for the enrichment, fortification and/or coloration of food beverages, animal feed, cosmetics or pharmaceutical compositions.2012-06-14
20120149783WATER-IN-OIL EMULSION COMPOSITIONS CONTAINING GELLAN GUM FOR TOPICAL DELIVERY OF ACTIVE INGREDIENTS TO THE SKIN OR MUCOSA - The present invention is directed to water-in-oil (W/O) emulsion compositions containing gellan gum which provide an enhanced rate of release of active ingredients for delivery to the skin or mucosa.2012-06-14
20120149784TABLETTING OF ERYTHRITOL AND ISOMALT - Erythritol is granulated together with from 10% w/w to 50% w/w isomalt. Chewable tablets are prepared and the corresponding process is described.2012-06-14
20120149785METHOD OF ESTIMATING SEPSIS RISK IN AN INDIVIDUAL WITH INFECTION - A method of estimating sepsis risk in an individual with infection comprises a step of assaying a biological sample from the individual for an IL-2 or IL-7 mRNA value, and correlating the mRNA value with sepsis risk. The IL-2 and IL-7 mRNA values are quantified by absolute quantification of mRNA copy number, wherein the copy numbers are normalised to a house keeping gene and corrected against a calibration curve for serial dilutions of the IL-2 and IL-7 cDNA. The method generally involves a step of assaying a biological sample from the individual for IL-2 and/or IL-7 mRNA values, optionally in combination with mRNA values for other cytokines, and correlating a sum or difference of the values with sepsis risk using a regression analysis curve against outcome.2012-06-14
20120149786SYSTEM AND METHOD FOR PREPARING LIQUID FUELS - Techniques, methods and systems for preparation liquid fuels from hydrocarbon and carbon dioxide are disclosed. The present invention can transform hydrocarbon and carbon dioxide generated from organic feed stocks or other industrial emissions into renewable engineered liquid fuels and store them in a cost-efficient way. The method of the present invention includes: supplying hydrocarbon and carbon dioxide to a heated area of a reaction chamber in controlled volumes; forming carbon monoxide by the energy provided by the heated area; transporting carbon monoxide and hydrogen to an reactor in controlled volumes; supplying additional hydrogen to the reactor; regulating the pressure in the reactor by adjusting the controlled volumes in order to achieve a predetermined object; forming the liquid fuel in the reactor according to the predetermined object; and, storing the liquid fuel in a storage device.2012-06-14
20120149787FISCHER-TROPSCH CATALYSTS - A method of producing an alumina-supported cobalt catalyst for use in a Fischer-Tropsch synthesis reaction, which comprises: calcining an initial γ-alumina support material at a temperature to produce a modified alumina support material; impregnating the modified alumina support material with a source of cobalt; calcining the impregnated support material, activating the catalyst with a reducing gas, steam treating the activated catalyst, and activating the steam treated catalyst with a reducing gas.2012-06-14
20120149788COMBINED REFORMING PROCESS FOR METHANOL PRODUCTION - The invention relates to a combined reforming process for making synthesis gas from a desulphurised gaseous hydrocarbon feedstock, wherein the feedstock is split into a first and a second feedstock stream, the first feedstock stream is mixed with steam and fed to a gas heated reformer (GHR) and a steam methane reformer (SMR) operated in series, and the second feedstock stream is mixed with reformed gas coming from the SMR and fed with oxygen to a non-catalytic partial oxidation reformer (POX). The process of the invention enables to produce syngas with adjustable composition and at very high capacity in a single line. The process specifically allows designing a methane-to-methanol production plant with a capacity exceeding 10000 mtpd using technically and economically feasible reforming equipment, and showing high feedstock and energy efficiency. The invention further relates to an integrated process for making methanol from a hydrocarbon feedstock comprising said combined reforming process.2012-06-14
20120149789Apparatus and Method for the Electrolysis of Water - An apparatus for the electrolytic splitting of water into hydrogen and/or oxygen, the apparatus comprising: (i) at least one lithographically-patternable substrate having a surface; (ii) a plurality of microscaled catalytic electrodes embedded in said surface; (iii) at least one counter electrode in proximity to but not on said surface; (iv) means for collecting evolved hydrogen and/or oxygen gas; (v) electrical powering means for applying a voltage across said plurality of microscaled catalytic electrodes and said at least one counter electrode; and (vi) a container for holding an aqueous electrolyte and housing said plurality of microscaled catalytic electrodes and said at least one counter electrode. Electrolytic processes using the above electrolytic apparatus or functional mimics thereof are also described.2012-06-14
20120149790RECYCLED BUILDING MATERIAL AND METHOD THEREOF - The present invention provides a recycled building material such as roof/Geo membrane that comprises (i) a polyolefin, (ii) a polymer containing a carboxyl group or a hydroxyl group, and (iii) a compatabilizer for the components (i) and (ii) which contains an epoxy group or an anhydride group. The present invention also provides a method of recycling building material as well as an article of manufacture such as a TPO membrane using the recycled building material. The TPO membrane has gained better physical properties such as consistent product quality, tensile strength, tear strength, wind resistance, and avoidance of tedious screening processes, among others.2012-06-14
20120149791OLIGOMERIC PRODUCTS OF POLYETHYLENE TEREPHTHALATE (PET) AND METHODS OF MAKING AND USING SAME - The presently disclosed and claimed inventive concept(s) relates generally to the method of producing a resin replacement compound, the resin replacement compound itself, and the use of the resin replacement compound. More particularly, but not to be construed as limiting, the presently disclosed and claimed inventive concept(s) relate to the recovery of an oligomeric form of polyethylene terephthalic acid from waste polyethylene terephthalate. In one particular aspect, the presently disclosed and claimed inventive concept(s) relate to the recovery of an oligomeric form of polyethylene terephthalic acid from waste products, such as beverage containers, made from polyethylene terephthalate. In an additional aspect, the presently disclosed and claimed inventive concept(s) relate to the use of a recovered oligomeric form of polyethylene terephthalic acid in a toner composition.2012-06-14
20120149792EXPANDABLE MODIFIED RESIN BEADS, EXPANDED MODIFIED RESIN BEADS, AND FOAMED MOLDED ARTICLE FORMED FROM EXPANDED MODIFIED RESIN BEADS - Disclosed is expandable modified resin beads (2012-06-14
20120149793MONOMODAL EXTRUDED POLYSTYRENE FOAM - Prepare an extruded polystyrene foam article by extruding a foamable polymer composition containing polystyrene homopolymer, a blowing agent containing 0.5 to three weight-parts water and 0.1 to five weight parts halloysite clay particles, with weight-parts relative to 100 weight-parts total polymer.2012-06-14
20120149794N,N,N'-Trimethyl-Bis-(Aminoethyl) Ether and its Derivatives as Catalysts for Polyurethanes - The present invention provides compounds produced by the reaction of glycidyl ethers and glycidyl esters with ether compounds including N,N,N′-trimethyl-bis-(aminoethyl)ether. N,N,N′-trimethyl-bis-(aminoethyl)ether and its derivatives can be used as polyurethane catalysts.2012-06-14
20120149795POLYURETHANE FOAMS CONTAINING INCORPORATED PHASE CHANGE MATERIAL - The invention relates to polyurethane foams with incorporated phase change material, especially for reinforcing the back of deep-drawn films and components.2012-06-14
20120149796METHOD FOR PRODUCING LOW-HALOGEN POLYBIPHENYLSULFONE POLYMERS - The present invention relates to a process for the production of low-halogen-content polybiphenyl sulfone polymers, to the resultant polybiphenyl sulfone polymers, to polybiphenyl sulfone polymers having less than 400 ppm content of polymer-bonded halogen, to thermoplastic molding compositions comprising these polybiphenyl sulfone polymers, and to their use for the production of moldings, of fibers, of films, of membranes, or of foams.2012-06-14
20120149797INK COMPOSITION, INKJET RECORDING METHOD, PRINTED MATERIAL, METHOD FOR PRODUCING PLANOGRAPHIC PRINTING PLATE, AND PLANOGRAPHIC PRINTING PLATE - The invention provides an ink composition having at least (A) a polymerization initiator, (B) an ester or amide of (meth)acrylic acid having a 1,3-dioxolane ring skeleton or a 1,3-dioxane ring skeleton or (B′) an ester or amide of (meth)acrylic acid having a 1,3-diketone structure, and (C) a colorant. The invention further provides an inkjet recording method and a method for producing a planographic printing plate, each of which includes at least (I) ejecting the ink composition onto a hydrophilic support and (II) curing the ink composition by irradiating the ejected ink composition with active radiation so as to form a hydrophobic image region on the hydrophilic support. The invention furthermore provides a planographic printing plate formed by the method for producing a planographic printing plate.2012-06-14
20120149798PHOTOCURABLE FLUORINATED POLYMER COMPOSITION - To provide a photocurable fluorinated polymer composition which has a high curing rate, shows little shrinkage before and after photocuring and requires no post treatment such as heat treatment after photocuring and whereby it is possible to obtain a cured resin excellent in heat resistance and weather resistance. According to the photocurable fluorinated polymer composition comprising a fluorinated polymer (A) containing polymerized units derived from a fluoroolefin and polymerized units derived from an unsaturated monomer having an oxetanyl group or a substituted oxetanyl group, and a photoreaction initiator (B), of the present invention, it is possible to provide a photocurable fluorinated polymer composition which has a high curing rate, shows little shrinkage before and after photocuring and requires no post treatment such as heat treatment after photocuring and whereby it is possible to obtain a cured resin excellent in heat resistance and weather resistance.2012-06-14
20120149799CELLULOSIC UV CURABLE COMPOSITIONS AND ARTICLES - Cellulosic ultra-violet curable coating compositions, coatings and articles made from the compositions, and methods for making such coatings and articles and compositions are disclosed and claimed. Such coatings exhibit superior adhesion and hardness, without appreciable curl.2012-06-14
20120149800POLYMERIZABLE IONIC LIQUID COMPRISING MULTIFUNCTIONAL CATION AND ANTISTATIC COATINGS - A multifunctional polymerizable ionic liquid is described comprising an anion and a cationic group having at least two ethylenically unsaturated polymerizable groups, each bonded to the cationic group via a divalent non-alkyl linking group. The multifunctional linking groups independently comprise a heteroatom such as oxygen or nitrogen. The linking groups may independently comprise one or more linkages such as an amide, urea, or ether linkage and more typically a urethane or ester linkage. The ethylenically unsaturated polymerizable groups are typically (meth)acrylate groups. Coatings and coated articles are also described.2012-06-14
20120149801DENTAL COMPOSITION - An aqueous dental glass ionomer composition comprising (a) a reactive particulate glass, and (b) a linear or branched polymer comprising acidic groups, which is reactive with the particulate glass in a cement reaction, whereby the linear or branched polymer comprising acidic groups has a polymer backbone and optionally pendant side chains, (c) optionally dispersed nanoparticles, and (d) optionally a low molecular compound, characterized in that the glass ionomer composition comprises —S2012-06-14
20120149802COMPOSITES HAVING DISTORTIONAL RESIN COATED FIBERS - A fiber reinforced resin composite includes a coating on the fibers that improves load transfer between the fibers and the surrounding resin matrix.2012-06-14
20120149803AUTOXIDISABLE AQUEOUS COATING COMPOSTIONS - An autoxidisable aqueous varnish composition comprising: a) film forming polymer latex binder system comprising, on a non-vol basis, i) 40-60 wt % soft autoxidisable polymer particles of Fox Tg less than 5° C., ii) 60-40 wt % hard polymer particles of Fox Tg at least 40° C. wherein the soft autoxidisable polymer particles comprise at least 60 wt % gel b) a carrier liquid comprising at least 50 wt % water and an amount of a volatile organic material of from 0 to 2 wt % when calculated on the total liquid varnish composition, c) optionally pigment at a pigment to binder weight ratio up to 0.05:1 calculated on a non-vol basis.2012-06-14
20120149804EPOXY SYSTEMS AND AMINE POLYMER SYSTEMS AND METHODS FOR MAKING THE SAME - Compositions and methods for forming surfactants, aqueous dispersions, and curing agents are provided. In one aspect, the invention relates to improved epoxy functional surfactants prepared by reaction of an epoxy composition and an amidoamine composition formed from a blend of acid-terminated polyoxyalkylene polyols. The improved epoxy functional surfactants may be reacted with an excess of epoxy composition and water to result in an aqueous dispersion. The amidoamone composition may be a reaction mixture of a diamine compound and an acid terminated polyoxyalkylene composition formed from two or more polyoxyalkylene polyol compounds. The epoxy functional surfactant may be reacted with amine compounds to form a compound suitable as a curing agent.2012-06-14
20120149805EPOXY SYSTEMS AND AMINE POLYMER SYSTEMS AND METHODS FOR MAKING THE SAME - Compositions and methods for forming surfactants, aqueous dispersions, and curing agents are provided. In one aspect, the invention relates to improved epoxy functional surfactants prepared by reaction of an epoxy composition and an amidoamine composition formed from a blend of acid-terminated polyoxyalkylene polyols. The improved epoxy functional surfactants may be reacted with an excess of epoxy composition and water to result in an aqueous dispersion. The amidoamone composition may be a reaction mixture of a diamine compound and an acid terminated polyoxyalkylene composition formed from two or more polyoxyalkylene polyol compounds. The epoxy functional surfactant may be reacted with amine compounds to form a compound suitable as a curing agent.2012-06-14
20120149806RUBBER COMPOSITION AND PNEUMATIC TIRE - A rubber composition that can improve in good balance the fuel economy, wet-grip performance, and abrasion resistance, and a pneumatic tire that uses this rubber composition are provided. This rubber composition contains a rubber component, and carbon black and/or silica, wherein based on 100% by mass of the rubber component, the rubber component contains 5 to 50% by mass of natural rubber, 0.3 to 10% by mass of an epoxidized natural rubber, and at least 5% by mass of a conjugated diene polymer that has a constituent unit based on a conjugated diene and a constituent unit represented by formula (I) below, at least one terminal of the polymer being modified, and wherein a total content of the carbon black and the silica is 3 to 100 parts by mass per 100 parts by mass of the rubber component.2012-06-14
20120149807DIEPOXY COMPOUND, PROCESS FOR PRODUCING SAME, AND COMPOSITION CONTAINING THE DIEPOXY COMPOUND - A diepoxy compound represented by the formula (1)2012-06-14
20120149808Curable casting compound containing keratin fibers and plastic moulded parts produced therefrom - In order to provide a curable casting compound for producing plastic moulded parts, comprising a binder component based on polymerizable monomers selected from methyl acrylate or methyl methacrylate and a proportion of about 40 to about 85% by weight of one or more inorganic fillers, which compound can be used for producing plastic moulded parts having an increased impact strength, it is proposed that the casting compound comprise 0.1 to 0.5% by weight of keratin fibres.2012-06-14
20120149809VINYL CHLORIDE RESIN COMPOSITION FOR TRANSPARENT PRODUCTS - The present invention is the vinyl chloride resin composition for transparent products, characterized in that (A) 0.001˜10 mass parts of at least one kind of organic acid zinc salts, (B) 0.001˜10 mass parts of at least one kind of zinc-modified hydrotalcite compounds and (C) 0.001˜1.0 mass parts of at least one kind selected from a group consisting of mannitol, maltitol and lactitol are contained relative to 100 mass parts of vinyl chloride resin. Transparent molded products of the present invention, obtained by molding the said composition, has characteristics such as thermal resistance, coloring resistance and thermal coloring resistance as well as maintaining high transparency.2012-06-14
20120149810Adhesive composition - The invention relates to an adhesive composition comprising hydrophilic silicone elastomers and hydrophobic silicone elastomers and optionally water absorbent material, wherein the ratio between the hydrophilic silicone elastomers and the hydrophobic silicone elastomers is from 95:5 to 5:95. The adhesive is suited for medical use due to its skin-friendliness. The invention further relates to a medical device comprising said adhesive composition.2012-06-14
20120149811Architectural Paint for Covering Defects - An architectural paint is disclosed which comprises a film-forming binder polymer, cotton fibers, and glass bubbles. The paint, in some embodiments, is capable of covering defects in a wall surface.2012-06-14
20120149812TOP COATING FOR INDOOR AND OUTDOOR TEMPORARY REMOVABLE GRAPHICS AND SYSTEM AND METHOD FOR MAKING, APPLYING AND REMOVING SUCH GRAPHICS - A composition for a removable top coating for protecting the exposed face of a temporary removable graphic is provided. A remover for the transferred graphic image is provided that completely dissolves the temporary removable graphic, but does not affect the commonly encountered substrates such as concrete, brick, wooden floors, asphalt surfaces, terrazzo and motor vehicle body surfaces, marine and aeronautical craft surfaces. A method for making, applying and removing the temporary removable graphic is provided.2012-06-14
20120149813Soy composite materials comprising an amino resin and methods of making the same - The present invention provides composite materials derived from aqueous binder compositions comprising defatted soy flour of no greater than 43 micron mesh particle size, polymer particles of at least one emulsion (co)polymer, one or more amino resin, and, optionally, one or more reducing sugar. Also provided are methods of making and using composite materials containing the binder compositions.2012-06-14
20120149814ULTRAHYDROPHOBIC COATING AND METHOD FOR MAKING THE SAME - Compositions for making ultrahydrophobic coatings are described. The compositions comprise microclusters having particles with diameters from 5 nm to 25 microns. The coatings applied are ultrahydrophobic and display a contact angle against water of greater than 130° and a sliding angle of less than 20°.2012-06-14
20120149815Transparent Layer Forming Polymer - Embodiments in accordance with the present invention provide polymers for forming layers/films useful in the manufacture of a variety of types of optoelectronic displays. Such embodiments also provide compositions of such polymers for forming such layers/films where the formed layers/films have high transparency over the visible light spectrum.2012-06-14
20120149816Eco-Friendly Polyamide Resin Composition Having Flame Retardancy - A flame retardant thermoplastic resin composition includes (A) about 20 to about 99.49 wt % of an aromatic polyamide resin; (B) 0 to about 50 wt % of a polyphenylene sulfide resin; (C) about 0.5 to about 30 wt % of a phosphinic acid metal salt flame retardant; (D) about 0.01 to about 10 wt % of a zinc compound; and (E) 0 to about 70 wt % of a filler comprising an organic filler, an inorganic filler, or a combination thereof. The flame retardant thermoplastic resin composition can have excellent heat resistance, mechanical strength and processability, a low moisture absorption rate and can inhibit corrosion of a metal surface of an extruder or a mold. The flame retardant thermoplastic resin composition can be used for various electrical electronic parts or auto parts as an environmentally friendly flame retardant thermoplastic resin composition.2012-06-14
20120149817THERMAL AGING-RESISTANT POLYAMIDES - Thermoplastic molding compositions comprising 2012-06-14
20120149818COMPOSITION BASED ON NATURAL RUBBER AND A POLYAMINE COMPOUND - Reinforced rubber composition, exhibiting improved hysteresis, based on at least (a) an elastomeric matrix predominantly based on natural rubber, (b) a reinforcing filler and (c) a specific polyamine compound present in a proportion of between 0 and 7 mmol per 100 g of elastomer.2012-06-14
20120149819ORGANIC SILICON COMPOUND, THERMOSETTING COMPOSITION CONTAINING SAID ORGANIC SILICON COMPOUND, AND SEALING MATERIAL FOR OPTICAL SEMICONDUCTOR - A liquid organosilicon compound comprising a structural unit represented by the following formula (1-a) and a structural unit represented by the following formula (1-b):2012-06-14
20120149820NON-AQUEOUS DISPERSIONS COMPRISING A NONLINEAR ACRYLIC STABILIZER - A non-aqueous dispersion comprising the dispersion polymerization reaction product of an ethylenically unsaturated monomer and a nonlinear, random acrylic polymer stabilizer is disclosed. Related coatings, methods, and substrates are also disclosed.2012-06-14
20120149821PROCESS FOR STABILIZING HYPOPHOSPHITE SALTS - The current invention relates to a process for stabilizing a hypophosphite salt, comprising the step of heating the hypophosphite salt at a temperature of between 150 and 370° C. during a sufficient period of time to prevent the formation of a dangerous quantity of phosphine in their application as FR in polymers and a flame retardant polymer composition comprising a polymer and 0.1 to 30 weight percent based on the total weight of the composition of the hypophosphite salt thermally stabilized by the above process.2012-06-14
20120149822PNEUMATIC OBJECT PROVIDED WITH A GASTIGHT LAYER MADE OF A THERMOPLASTIC ELASTOMER AND LAMELLAR FILLER - An inflatable object is equipped with a layer for sealing in an inflation gas. The layer is formed of an elastomeric composition that includes a predominant elastomer by weight, a block thermoplastic elastomer, and a lamellar filler. The block thermoplastic elastomer includes a polyisobutylene block with a number-average molecular mass ranging from 25,000 to 350,000 g/mol and a glass transition temperature of less than or equal to −20° C., and, at at least one end of the polyisobutylene block, a thermoplastic block made from at least a polymerized monomer other than a stirene monomer, the polymerized monomer having a glass transition temperature greater than or equal to 100° C. The lamellar filler has an equivalent diameter (D2012-06-14
20120149823Thermoplastic Polymeric Ovenware - Ovenware made from thermoplastic polymeric compositions which have relatively high thermal conductivities has advantages in cooking food. Such compositions can be made by mixing a thermoplastic polymer with a particulate material which has a relatively high thermal conductivity. This composition usually allows to faster heating of the food and/or improved browning of the food in contact with the ovenware surface.2012-06-14
20120149824CARBON NANOTUBE AGGLOMERATE - The invention relates to a method for producing carbon nanotubes in the agglomerated form and thus obtained novel carbon nanotube agglomerates.2012-06-14
20120149825COLD SHRINKABLE ARTICLE INCLUDING AN EPICHLOROHYDRIN COMPOSITION - A composition includes an elastomeric composition. The elastomeric composition can include an epichlorohydrin composition, and the elastomeric composition can be substantially free of a fluoroelastomer composition. The composition can further include a filler material which includes a reinforcement-grade carbon black. The composition can further include a peroxide curative.2012-06-14
20120149826Tapered Asymmetric Block Copolymers and Adhesives Composition Comprising the Same - Provided is a tapered block copolymer having asymmetric vinyl aromatic blocks. The disclosed tapered block copolymer has very superior adhesion properties such as loop tack, 180° peel strength and softening point and may be used to prepare high-quality hot melt adhesives for industrial use.2012-06-14
20120149827Low Application Temperature Hot Melt Adhesive - The invention relates to a low application temperature hot melt adhesive. More specifically, the low application temperature hot melt adhesive comprises olefin copolymers with an average Melt Index greater than 5 but less than about 35 g/10 minutes at 190° C. The adhesive is particularly useful in the construction of nonwoven articles.2012-06-14
20120149828WATERBORNE POLYISOCYANATE COMPOSITION THAT PROVIDES A LOW FRICTION COATING - The present invention is a chemical composition that provides a low friction coating and a low sliding coefficient of friction onto a plastic or metal working part that includes a waterborne polyisocyanate such as ureas, urethanes or tetramethylxylene diisocyanates (TMXDI) in the composition structure and a plurality of cross linkable functional groups that include carboxyl groups and hydroxyl groups that are added utilizing plasma or chemical grafting and etching and a plastic or metal chemical substrate. The composition also includes one or more materials that are single linked or multiple linked hydrogels such as polyvinylpyrrolidone (PVP), polyethylene glycol (PEG) or polyvinyl alcohol (PVA) mixed with the polyisocynate and one or more crosslinkers such as aziridines or carbodiimides that link the hydrogels, the polyisocynate and the substrate together to form the composition.2012-06-14
20120149829Polymerization Process And Adhesives Therefrom - This invention relates to a propylene polymer comprising a component having a crystallinity of 10% or less and a component having a crystallinity of 20% or more, said propylene polymer having: 2012-06-14
20120149830POLYESTER FILM AND METHOD OF FABRICATING THE SAME - A polyester film is described, including a first polyester and a second polyester. The weight ratio of the first polyester to the second polyester ranges from 1:1 to 1:3. The glass transition temperature of the first polyester is higher than 140° C. and that of the second polyester is lower than 140° C.2012-06-14
20120149831BINDER FOR INKJET PRINTING INK, INKJET PRINTING INK CONTAINING THE BINDER, AND PRINTED PRODUCT - The present invention relates to a binder for an inkjet printing ink, the binder including a polysiloxane (A), a hydrophilic-group-containing polyurethane (B), and an aqueous medium (C), wherein the polysiloxane (A) and the hydrophilic-group-containing polyurethane (B) form composite resin particles and the polysiloxane (A) is dispersed in the aqueous medium (C) with the hydrophilic-group-containing polyurethane (B); an ink for inkjet printing; and a printed product.2012-06-14
20120149832NON-AQUEOUS DISPERSION OF POLYMER PARTICLES IN REACTIVE DILUENT - The invention relates to a non-aqueous dispersion of organic polymer particles in a reactive diluent. Said non-aqueous dispersion can be obtained in that at least one monomer is polymerized in the reactive diluent, forming the organic polymer particles, wherein the reactive diluent does not participate in said polymerization due to the orthogonal reactivity thereof relative to the monomers, but comprises a functionality allowing later targeted polymerization. Depending on the organic polymer particles or reactive diluents used, the non-aqueous dispersion can be used in multifaceted applications having a wide range of application profiles. In order to produce said non-aqueous dispersion, polymerization of at least one monomer in a stirred tank reactor in the presence of a reactive diluent is particularly suitable, wherein the conversion is performed at a stirring speed of at least 2 m/s, wherein the ratio of the stirrer diameter to the vessel diameter is set to 0.3-0.80 and the distance from the stirrer to the vessel floor is set to 0.25 to 0.5 times the stirrer diameter. The invention provides multifaceted advantageous applications, particularly as an impact strength modifier, particularly in films, and as an adhesive, as casting resin, or as paint. A particularly advantageous application is producing a molded part or a semi-finished polymer product.2012-06-14
20120149833POLYMERS FUNCTIONALIZED WITH OXIME COMPOUNDS CONTAINING AN ACYL GROUP - A method for preparing a functionalized polymer, the method comprising the steps of polymerizing monomer to form a reactive polymer; and reacting the reactive polymer with a protected oxime compound containing an acyl group.2012-06-14
20120149834Polyethylene for Rotomoulding - A novel polyethylene is devised which polyethylene is particularly advantageous for manufacturing rotomoulded articles.2012-06-14
20120149835SULPHUR CEMENT PRE-COMPOSITION AND SULPHUR CEMENT PRODUCT - A sulphur cement pre-compositionr comprising sulphur and a polysiloxane is disclosed. The polysiloxane comprises a sulphur reactive functional group and/or a hydrolysable group. Sulphur cement products, wax-based pre-compositions, processes for preparing sulphur cement pre-compositions and processes for preparing sulphur cement products are also disclosed.2012-06-14
20120149836METHOD FOR THE PREPARATION OF HIGH MOLECULAR WEIGHT OLIGO(ALKYLENE GLYCOL) FUNCTIONALIZED POLYISOCYANOPEPTIDES - The present invention relates to a process for the preparation of oligo(alkylene glycol) functionalized polyisocyanopeptides comprising the steps of functionalizing an isocyanopeptide with oligo-(alkylene glycol) side chains and subsequently polymerizing the oligo-alkylene glycol functionalized isocyanopeptides. Several isocyanopeptide may be functionalized with various linear or non-linear oligo-(alkylene glycol) side chains having variable chain length. The alkylene glycol may be selected from the group consisting of ethylene-, propylene-, butylene- or pentylene glycol. Preferably the isocyanopeptides are functionalized with at least 3 ethylene glycol side chains. The peptides may comprise L aminoacids, D-aminoacids or D, L-aminoacids. The obtained oligoalkylene functionalized polyisocyanopeptides are a new class of materials with unique thermo-responsive properties.2012-06-14
20120149837THERMOPLASTIC RESIN COMPOSITION - A thermoplastic resin composition obtained by mixing 100 parts by weight of at least one thermoplastic resin (A) with 0.1 to 4 parts by weight of (B) a polyfunctional compound having three or more functional groups in which at least one of the terminal structures haying the functional groups is a structure represented by formula (1):2012-06-14
20120149838METHOD FOR RECYCLING OF PHENOLIC ANTIOXIDANT AGENT, PROCESS FOR PRODUCTION OF OLEFIN POLYMER, POLYOLEFIN POWDER, AND FIBERS - Provided are a recycling method for industrially, simply and effectively recycling a phenolic body from a phenolic antioxidant which is masked by an organoaluminum compound and contained in an olefin polymer obtained by supplying the masked phenolic antioxidant upon polymerization; and an olefin polymer obtained by this method.2012-06-14
20120149839POLYCARBONATE NANOCOMPOSITES - Polycarbonate nanocomposites comprising a polycarbonate matrix having non-oxidized metal nanoparticles dispersed therein are disclosed. The polycarbonate nanocomposite is produced by a process comprising forming a reaction mixture comprising a dihydroxy compound, an activated carbonate, a metal precursor, and a solvent; and in-situ polymerizing the reaction mixture to form a nanocomposite comprising a polycarbonate matrix and metal nanoparticles dispersed therein. The metal precursor comprises a metal selected from a specified group. The nanocomposites have improved mechanical, optical, electrical and/or magnetic properties. Also disclosed are articles formed from such polycarbonate nanocomposites.2012-06-14
20120149840PROCESS FOR PRODUCING AN AQUEOUS POLYMER DISPERSION - Polymerizing an ethylenically unsaturdated monomer in an aqueous medium can produce an aqueous polymer dispersion. The polymerization is in the presence of a dispersant and a metal-carbene complex. The polymerization can also optionally be in the presence of a dispersant, an organic solvent with low solubility in water, or both. The aqueous polymer dispersion resulting from the process can be used to make a polymer powder.2012-06-14